176 related articles for article (PubMed ID: 11577486)
21. Cervical cancer.
Cohen PA; Jhingran A; Oaknin A; Denny L
Lancet; 2019 Jan; 393(10167):169-182. PubMed ID: 30638582
[TBL] [Abstract][Full Text] [Related]
22. Papanicolaou test and enzyme-linked in-situ hybridization. A combined diagnostic system for papilloma virus infections with high prognostic value.
Schön HJ; Czerwenka KF; Schurz B; Kramar R; Kubista E
Eur J Clin Chem Clin Biochem; 1991 Feb; 29(2):131-8. PubMed ID: 1646654
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing cervical cancer screening in women infected with HIV: a review of the literature.
Chapman Lambert CL
J Assoc Nurses AIDS Care; 2013; 24(3):189-97. PubMed ID: 22999769
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic vaccination for HPV induced cervical cancers.
Brinkman JA; Hughes SH; Stone P; Caffrey AS; Muderspach LI; Roman LD; Weber JS; Kast WM
Dis Markers; 2007; 23(4):337-52. PubMed ID: 17627067
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and treatment of human papilloma virus infections in cervico-vaginal screening].
Pavesi M; Castagnola G; Uboldi L; Fibbi ML; Grossi Canger E; Micelli R; Canevini P; Remotti G
Ann Ostet Ginecol Med Perinat; 1985; 106(4):225-35. PubMed ID: 3006577
[No Abstract] [Full Text] [Related]
26. Association between human papillomavirus infection and cytological abnormalities during early follow-up of invasive cervical cancer.
de Azevedo AE; Carneiro FP; Neto FF; Bocca AL; Teixeira LS; de Queiroz Maurício Filho MA; de Padua Nakashima J; de Abreu WC; Muniz-Junqueira MI; de Magalhães AV
J Med Virol; 2012 Jul; 84(7):1115-9. PubMed ID: 22585730
[TBL] [Abstract][Full Text] [Related]
27. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
Steller MA; Gurski KJ; Murakami M; Daniel RW; Shah KV; Celis E; Sette A; Trimble EL; Park RC; Marincola FM
Clin Cancer Res; 1998 Sep; 4(9):2103-9. PubMed ID: 9748126
[TBL] [Abstract][Full Text] [Related]
28. Human Papilloma Virus-Associated Cervical Cancer and Health Disparities.
Olusola P; Banerjee HN; Philley JV; Dasgupta S
Cells; 2019 Jun; 8(6):. PubMed ID: 31234354
[TBL] [Abstract][Full Text] [Related]
29. Screening for cervical cancer: which common technique is the most cost-effective choice?
Wiwanitkit V
Asian Pac J Cancer Prev; 2009; 10(3):531-2. PubMed ID: 19640204
[TBL] [Abstract][Full Text] [Related]
30. Re: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.
Strickler H; Shah K
J Natl Cancer Inst; 2001 Jun; 93(12):951; author reply 951-2. PubMed ID: 11416120
[No Abstract] [Full Text] [Related]
31. Adding a test for human papillomavirus DNA to cervical-cancer screening.
Wright TC; Schiffman M
N Engl J Med; 2003 Feb; 348(6):489-90. PubMed ID: 12571255
[No Abstract] [Full Text] [Related]
32. Re: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.
Harris JE
J Natl Cancer Inst; 2001 Jun; 93(12):950-1; author reply 951-2. PubMed ID: 11416118
[No Abstract] [Full Text] [Related]
33. Human papillomavirus and cervical disease in adolescents.
Guido R
Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
[TBL] [Abstract][Full Text] [Related]
34. Cervical cancer.
NIH Consens Statement; 1996 Apr 1-3; 14(1):1-38; quiz 4p. PubMed ID: 9407932
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities.
Burger MP; Hollema H; Pieters WJ; Quint WG
BMJ; 1995 Jan; 310(6972):94-5. PubMed ID: 7833734
[No Abstract] [Full Text] [Related]
36. Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types.
Phongsavan K; Gustavsson I; Marions L; Phengsavanh A; Wahlström R; Gyllensten U
Int J Gynecol Cancer; 2012 Oct; 22(8):1398-406. PubMed ID: 22932265
[TBL] [Abstract][Full Text] [Related]
37. Urine-based HPV testing as a method to screen for cervical cancer.
Fontenot HB
Nurs Womens Health; 2015; 19(1):59-65. PubMed ID: 25690816
[TBL] [Abstract][Full Text] [Related]
38. PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer.
Rohan T; Mann V; McLaughlin J; Harnish DG; Yu H; Smith D; Davis R; Shier RM; Rawls W
Int J Cancer; 1991 Dec; 49(6):856-60. PubMed ID: 1660038
[TBL] [Abstract][Full Text] [Related]
39. [Cervical cancer: new testing strategies?].
Heard I; Costagliola D
Med Sci (Paris); 2008 Nov; 24(11):977-8. PubMed ID: 19038102
[No Abstract] [Full Text] [Related]
40. The relationship of risk factors for cervical cancer and HPV in college women.
McQuiston CM
Nurse Pract; 1989 Apr; 14(4):18, 23, 26. PubMed ID: 2540467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
